NCT00002439View on ClinicalTrials.gov

A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Alitretinoin

Sponsors

Collaborators (1)

Ligand Pharmaceuticals
All Listed Sponsors
collaborator

Ligand Pharmaceuticals

INDUSTRY

lead

Anderson Clinical Research

INDUSTRY

NCT00002439 - A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter